Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2008 1
2012 1
2013 1
2014 1
2015 2
2016 7
2017 8
2018 2
2019 8
2020 7
2021 6
2022 3
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Bladder cancer.
Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y. Sanli O, et al. Nat Rev Dis Primers. 2017 Apr 13;3:17022. doi: 10.1038/nrdp.2017.22. Nat Rev Dis Primers. 2017. PMID: 28406148 Free article. Review.
The two subtypes have unique pathological features and different molecular characteristics. Indeed, The Cancer Genome Atlas project identified genetic drivers of muscle-invasive bladder cancer (MIBC) as well as subtypes of MIBC with distinct characteristics and therapeutic …
The two subtypes have unique pathological features and different molecular characteristics. Indeed, The Cancer Genome Atlas project i …
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
Takahashi M, Chong HB, Zhang S, Lazarov MJ, Harry S, Maynard M, White R, Murrey HE, Hilbert B, Neil JR, Gohar M, Ge M, Zhang J, Durr BR, Kryukov G, Tsou CC, Brooijmans N, Alghali ASO, Rubio K, Vilanueva A, Harrison D, Koglin AS, Ojeda S, Karakyriakou B, Healy A, Assaad J, Makram F, Rachman I, Khandelwal N, Tien PC, Popoola G, Chen N, Vordermark K, Richter M, Patel H, Yang TY, Griesshaber H, Hosp T, van den Ouweland S, Hara T, Bussema L, Dong R, Shi L, Rasmussen MQ, Domingues AC, Lawless A, Fang J, Yoda S, Nguyen LP, Reeves SM, Wakefield FN, Acker A, Clark SE, Dubash T, Fisher DE, Maheswaran S, Haber DA, Boland G, Sade-Feldman M, Jenkins R, Hata A, Bardeesy N, Suva ML, Martin B, Liau B, Ott C, Rivera MN, Lawrence MS, Bar-Peled L. Takahashi M, et al. bioRxiv [Preprint]. 2023 Oct 23:2023.10.20.563287. doi: 10.1101/2023.10.20.563287. bioRxiv. 2023. PMID: 37961514 Free PMC article. Updated. Preprint.
However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed DrugMap , an atlas of cysteine ligandability compiled across 416 cancer cell lines. ...
However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed DrugMap …
Opposing gene regulatory programs governing myofiber development and maturation revealed at single nucleus resolution.
Dos Santos M, Shah AM, Zhang Y, Bezprozvannaya S, Chen K, Xu L, Lin W, McAnally JR, Bassel-Duby R, Liu N, Olson EN. Dos Santos M, et al. Nat Commun. 2023 Jul 19;14(1):4333. doi: 10.1038/s41467-023-40073-8. Nat Commun. 2023. PMID: 37468485 Free PMC article.
To decipher these distinctive gene programs and how they respond to neural activity, we generated a combined multi-omic single-nucleus RNA-seq and ATAC-seq atlas of mouse skeletal muscle development at multiple stages of embryonic, fetal, and postnatal life. ...In skeletal …
To decipher these distinctive gene programs and how they respond to neural activity, we generated a combined multi-omic single-nucleus RNA-s …
Management of Orbital Fractures.
Kholaki O, Hammer DA, Schlieve T. Kholaki O, et al. Atlas Oral Maxillofac Surg Clin North Am. 2019 Sep;27(2):157-165. doi: 10.1016/j.cxom.2019.05.007. Epub 2019 Jun 25. Atlas Oral Maxillofac Surg Clin North Am. 2019. PMID: 31345491 Review. No abstract available.
Unfolded protein response and angiogenesis in malignancies.
Izadpanah A, Willingham K, Chandrasekar B, Alt EU, Izadpanah R. Izadpanah A, et al. Biochim Biophys Acta Rev Cancer. 2023 Mar;1878(2):188839. doi: 10.1016/j.bbcan.2022.188839. Epub 2022 Nov 19. Biochim Biophys Acta Rev Cancer. 2023. PMID: 36414127 Free PMC article. Review.
To characterize differences in UPR and UPR-mediated angiogenesis in malignancy, we employed a data mining approach using patient tumor data from The Cancer Genome Atlas (TCGA). The analysis of TCGA revealed differences in UPR between malignant samples versus their non-mali …
To characterize differences in UPR and UPR-mediated angiogenesis in malignancy, we employed a data mining approach using patient tumor data …
Tissue Expansion in the Head and Neck.
Radwan AM, Zide MF. Radwan AM, et al. Atlas Oral Maxillofac Surg Clin North Am. 2019 Sep;27(2):167-173. doi: 10.1016/j.cxom.2019.05.010. Epub 2019 Jul 2. Atlas Oral Maxillofac Surg Clin North Am. 2019. PMID: 31345492 Review. No abstract available.
Delaying Soft Tissue Repair.
Burk TF, Zide MF. Burk TF, et al. Atlas Oral Maxillofac Surg Clin North Am. 2019 Sep;27(2):175-180. doi: 10.1016/j.cxom.2019.05.008. Epub 2019 Jun 22. Atlas Oral Maxillofac Surg Clin North Am. 2019. PMID: 31345493 Review. No abstract available.
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
Takahashi M, Chong HB, Zhang S, Yang TY, Lazarov MJ, Harry S, Maynard M, Hilbert B, White RD, Murrey HE, Tsou CC, Vordermark K, Assaad J, Gohar M, Dürr BR, Richter M, Patel H, Kryukov G, Brooijmans N, Alghali ASO, Rubio K, Villanueva A, Zhang J, Ge M, Makram F, Griesshaber H, Harrison D, Koglin AS, Ojeda S, Karakyriakou B, Healy A, Popoola G, Rachmin I, Khandelwal N, Neil JR, Tien PC, Chen N, Hosp T, van den Ouweland S, Hara T, Bussema L, Dong R, Shi L, Rasmussen MQ, Domingues AC, Lawless A, Fang J, Yoda S, Nguyen LP, Reeves SM, Wakefield FN, Acker A, Clark SE, Dubash T, Kastanos J, Oh E, Fisher DE, Maheswaran S, Haber DA, Boland GM, Sade-Feldman M, Jenkins RW, Hata AN, Bardeesy NM, Suvà ML, Martin BR, Liau BB, Ott CJ, Rivera MN, Lawrence MS, Bar-Peled L. Takahashi M, et al. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22. Cell. 2024. PMID: 38653237
However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed "DrugMap," an atlas of cysteine ligandability compiled across 416 cancer cell lines. ...
However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed "DrugMap …
56 results